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Stability of the Parainfluenza Virus 5 Genome Revealed by Deep
Sequencing of Strains Isolated from Different Hosts and following
Passage in Cell Culture
Bert K. Rima,a Derek Gatherer,b* Daniel F. Young,c Hanna Norsted,c Richard E. Randall,c Andrew J. Davisonb
Centre for Infection and Immunity, School of Medicine, Dentistry and Biomedical Sciences, The Queen’s University of Belfast, Belfast, United Kingdoma; MRC-University of
Glasgow Centre for Virus Research, Glasgow, United Kingdomb; Centre for Biomolecular Sciences, School of Biology, University of St. Andrews, St. Andrews, United
Kingdomc
ABSTRACT
The strain diversity of a rubulavirus, parainfluenza virus 5 (PIV5), was investigated by comparing 11 newly determined and 6
previously published genome sequences. These sequences represent 15 PIV5 strains, of which 6 were isolated from humans, 1
was frommonkeys, 2 were from pigs, and 6 were from dogs. Strain diversity is remarkably low, regardless of host, year of isola-
tion, or geographical origin; a total of 7.8% of nucleotides are variable, and the average pairwise difference between strains is
2.1%. Variation is distributed unevenly across the PIV5 genome, but no convincing evidence of selection for antibody-mediated
evasion in hemagglutinin-neuraminidase was found. The finding that some canine and porcine, but not primate, strains are mu-
tated in the SH gene, and do not produce SH, raised the possibility that dogs (or pigs) may not be the natural host of PIV5. The
genetic stability of PIV5 was also demonstrated during serial passage of one strain (W3) in Vero cells at a high multiplicity of
infection, under conditions of competition with large proportions of defective interfering genomes. A similar observation was
made for a strainW3mutant (PIV5VC) lacking V gene function, in which the dominant changes were related to pseudorever-
sion in this gene. The mutations detected in PIV5VC during pseudoreversion, and also those characterizing the SH gene in ca-
nine and porcine strains, predominantly involved U-to-C transitions. This suggests an important role for biased hypermutation
via an adenosine deaminase, RNA-specific (ADAR)-like activity.
IMPORTANCE
Here we report the sequence variation of 16 different isolates of parainfluenza virus 5 (PIV5) that were isolated from a number of
species, including humans, monkeys, dogs, and pigs, over 4 decades. Surprisingly, strain diversity was remarkably low, regard-
less of host, year of isolation, or geographical origin. Variation was distributed unevenly across the PIV5 genome, but no con-
vincing evidence of immune or host selection was found. This overall genome stability of PIV5 was also observed when the virus
was grown in the laboratory, and the genome stayed remarkably constant even during the selection of virus mutants. Some of the
canine isolates had lost their ability to encode one of the viral proteins, termed SH, suggesting that although PIV5 commonly
infects dogs, dogs may not be the natural host for PIV5.
Avirus that was first isolated almost 6 decades ago from rhesusand crab-eating (cynomolgus) macaque kidney cells was
originally named simian virus 5 (SV5) because it was believed that
monkeys were its natural host (1, 2). However, wild monkeys do
not have antibodies against SV5 and appear to be infected in cap-
tivity after contact with humans (3–5), who can be infected natu-
rally (4, 6). Subsequently, it was shown that SV5 also causes kennel
cough in dogs, and as a consequence, it is often referred to in
veterinary circles as canine parainfluenza virus. In addition, the
virus has been isolated from pigs, and there is some evidence that
cats, hamsters, and guinea pigs can be infected (4, 7, 8). Because
SV5 has been isolated from numerous species, and its natural host
remains unidentified, it is now named parainfluenza virus 5
(PIV5).
Two issues have complicated studies on defining the host range
and prevalence of PIV5. First, the virus can appear as a contami-
nant of tissue culture cells, raising the possibility that some strains
may have been isolated accidentally. However, limited studies of
sequence diversity among strains suggest that this is unlikely to
have occurred frequently, if at all (7). Second, antigenic cross-
reactivity occurs between PIV5 and human parainfluenza virus 2
(PIV2) (9, 10). This led to an early suggestion that PIV5 (or SV5, as
it was called at the time) should be classified as PIV2 of monkeys
(11). However, sequencing studies confirmed that PIV5 and PIV2
belong to distinct species (Parainfluenza virus 5 andHuman para-
influenza virus 2, respectively; genus Rubulavirus, subfamily
Paramyxovirinae, family Paramyxoviridae, order Mononegavi-
rales) (12). Thus, for example, PIV5 hemagglutinin-neuramini-
dase (HN) shares only 43% amino acid sequence identity with its
PIV2 ortholog (13).
PIV5 has a nonsegmented, negative-sense RNA genome of
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15,246 nucleotides (nt). The genome contains seven genes, which
encode eight proteins and are flanked by 3=-leader and 5=-trailer
sequences at the genome ends. From the 3= end, the genome en-
codes the nucleocapsid protein (N), V protein (V), phosphopro-
tein (P), matrix protein (M), fusion protein (F), small hydropho-
bic protein (SH), HN, and large protein (L) or RNA polymerase
(8, 12). V and P are unusual in being encoded by a single gene
(V/P) and sharing the same initiation codon and 5=-coding region.
However, they differ in their 3=-coding regions, with the VmRNA
being a faithful copy of the genomic sequence and the P mRNA
being a frameshifted version generated during transcription by the
pseudotemplated addition of 2 extra G residues in a G tract. The
outcome is that the V and P proteins share an N-terminal domain
of 164 amino acid residues but differ in their C-terminal domains
(58 and 228 residues, respectively).
Complete PIV5 genome sequences have been deposited in
public databases for the simian strain W3 (also called W3A), the
human strain cryptovirus, and, recently, three canine strains and
one porcine strain (Table 1). We have assessed PIV5 diversity by
resequencing strainW3 and also determining the sequences of five
human strains, three canine strains, and a porcine strain. In addi-
tion, we have investigated the stability of the PIV5 genome during
passage in cell culture at a high multiplicity of infection (MOI) of
strain W3 and a W3-derived mutant lacking a functional V gene.
We found that the PIV5 genome exhibits low diversity both in vivo
and in vitro and also that SH is not essential for infection of dogs or
pigs.
MATERIALS AND METHODS
PIV5 strains. Genome sequences were determined for strains DEN, RQ,
LN,MEL, andMIL (6);W3 (1) (kindly provided by Robert Lamb, North-
western University, USA); 78524 and H221 (kindly provided by Oswald
Jarrett, University of Glasgow, United Kingdom); SER (14) (kindly pro-
vided by Hans-Dieter Klenk, Philipps Universität, Marburg, Germany);
and CPI and its variant CPI (15, 16). Details of these viruses are given
in Table 1.
Preparation and sequencing of PIV5 RNA. Viruses were grown in
Vero cell monolayers at 37°C in Dulbecco’s modified Eagle’s medium
supplemented with 10% fetal bovine serum (17). Cells grown in roller
bottles were infected with PIV5 at an MOI of 10 PFU/cell. At 2 days
postinfection, nucleocapsids in the form of ribonucleoproteins were pu-
rified from infected cells by a series of centrifugation steps, and genomic
RNA was isolated, as described previously (17).
Viral RNAs were reverse transcribed, and the DNA was sequenced by
standard approaches, using an Illumina GAIIx instrument. Reads with a
length of 73 nt were aligned initially to the published strain W3 genome
sequence (GenBank accession numberAF052755) by usingMaq (18), and
the assembly was viewed by using Tablet (19). The reads for each strain
were then aligned to the appropriate, derived consensus sequence, and the
final assemblies were confirmed by inspection.Details of the read data and
the GenBank accession numbers of the sequenced genomes are listed in
Table 1.
Data on single-nucleotide polymorphisms (SNPs) within each ge-
nome sequence were extracted by using Maq, assessed to ensure their
representation on both strands of the DNA sequence, and checked by
viewing the alignments. The percentage of genomes containing each SNP
was calculated by using a script (read_cleaner; D. Gatherer, unpublished
data) to count the numbers of reads containing the variant nucleotide
flanked on each side by 10 nt (20). In a few instances, adjustments were
made to the sequence or positioning of this 21-nt region in order to cater
for the location of SNPs close to each other or near the 3= end of the
genome.
The published genome sequences of PIV5 strains W3 (21), crypto-
virus, 1168-1, D277, 08-1990, and KNU-11 (22) were obtained from
GenBank (Table 1).
Bioinformatic analyses. Sixteen of the sequences listed in Table 1
were aligned by using ClustalW implemented in MEGA 5.2 (23); that of
the original version of strain W3 [W3(cl)] (see below) was excluded. A
maximum likelihood tree was drawn in MEGA by using a general time-
reversible, gamma-distributed (GTR) nucleotide substitution model.
Nucleotide substitutionwas quantified inDNASp (24) by using the Jukes-
Cantor substitution model over a sliding window of 500 nt. Codeml, as
implemented in the PAML suite (25), was used to identify residues that
have potentially evolved under positive selection and to calculate the ratio
of nucleotide transitions to transversions (). Sequence distance matrices
were calculated in MEGA by using the maximum compositional likeli-
hood model with a gamma rate variation distribution.
Immunological detection of PIV5 SH. Vero cell monolayers in 25-
cm2 plates were infectedwith strainW3, CPI, CPI, or SER at anMOI of
10 PFU/cell. Cell lysates were prepared at 16 h postinfection, and proteins
were separated by SDS-PAGE and transferred onto nitrocellulose mem-
branes. Membranes were probed by using a polyclonal peptide antiserum
TABLE 1 Information on the PIV5 genome sequences determined in this study (with read data) or deposited by others
PIV5 strain Host source Country of origin
Decade of
isolation
GenBank
accession no.
No. of
Illumina reads
% matching
reads
MEL Human UK 1970s JQ743325 2,711,800 92
MIL Human UK 1970s JQ743326 2,452,893 88
DEN Human UK 1970s JQ743322 2,222,620 89
LN Human UK 1970s JQ743324 2,229,468 83
RQ Human UK 1970s JQ743327 2,070,127 77
W3(cl) Macaque USA 1960s AF052755
W3 Macaque USA 1960s JQ743318 21,156,178 78
Cryptovirus Human USA Not known AX586923
SER Pig Germany 1990s JQ743328 1,634,295 71
KNU-11 Pig South Korea 2010s KC852177
CPI Dog Germany 1980s JQ743321 1,505,580 59
CPI Dog Germany 1980s JQ743320 1,441,355 64
1168-1 Dog South Korea 2000s KC237064
78524 Dog UK 1980s JQ743319 2,294,166 78
H221 Dog UK 1980s JQ743323 2,251,985 86
08-1990 Dog South Korea 2000s KC237063
D277 Dog South Korea 2000s KC237065
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against strainW3 SH (kindly provided by Biao He, University of Georgia,
USA), a monoclonal antibody against strain LN P (SV5-Pe) (26), or a
monoclonal antibody against cellular -actin (catalog number A5441;
Sigma). Bound antibody was revealed by incubation with horseradish
peroxidase-conjugated secondary antibody (catalog number A9169 or
A9044; Sigma) and visualized by enhanced chemiluminescence (catalog
number 80196; Pierce).
Analysis of PIV5 diversity during passage in vitro. Previously, we
generated PIV5 stocks rich in defective interfering (DI) particles by pas-
saging at a high MOI (17). Briefly, Vero cell monolayers in 75-cm2 flasks
were infected at anMOI of 5 PFU/cell with a low-passage-number stock of
strainW3 (W3vM0). The culturemediumwas harvested every 2 to 3 days,
and half was then used for analysis and the other half was used to infect
another flask of cells. Twelve passages of strainW3 (W3vM1 toW3vM12)
were performed. To monitor pseudoreversion of PIV5VC (originally
called rSV5VC [27]), the virus was passaged 6 times in Vero cells from a
working stock to generate PIV5VCp6.
RNA was isolated from purified nucleocapsids from the later strain
W3 passages (W3vM8 to W3vM12), and sequence data were derived as
described previously (17). Reads with a length of 73 nt were aligned to the
W3vM0 sequence (GenBank accession number JQ743318) (Table 1), and
the alignments were visualized by using Tablet. Similarly, reads with a
length of 76 nt obtained from PIV5VCp6 RNA were aligned to the
PIV5VC genome sequence. We have utilized the sequence data for
W3vM0 and W3vM12 to characterize the DI populations in these virus
stocks (17). SNPs were identified, and the proportions of variant nucleo-
tides were determined, as described above. SNPs in a small region of the V
open reading frame (ORF), in which pseudoreversion occurred, were in-
vestigated by identifying reads containing the flanking sequences and
counting the numbers containing various combinations of variants in the
intervening sequence.
Nucleotide sequence accession numbers. The sequences determined
in this study were deposited in the GenBank database under accession
numbers JQ743318 to JQ743328.
RESULTS
Sequence relationships among PIV5 strains.We generated a to-
tal of 11 new PIV5 genome sequences by deep sequencing of
genomic RNA isolated from purified nucleocapsids derived from
infected cells (Table 1). The consensus sequences of the newly
analyzed PIV5 strains were compared among each other and the
six PIV5 sequences available from GenBank (Table 1). The newly
derived sequence for strain W3 was generated from an uncloned
virus stock that we originally obtained fromRobert Lamb (North-
western University, USA). It differs from the sequence deposited
previously in GenBank (21), which was derived from cloned
cDNA and which we refer to as W3(cl), by four synonymous sub-
stitutions (nt 505, 5882, 8164, and 9844) and twononsynonymous
substitutions (nt 4210 inM, resulting inG rather thanV at residue
357, and nt 4599 in F, resulting in T rather than A at residue 24).
From comparisons with the other strains, it was apparent that the
differences at nt 505, 4210, 5882, 8164, and 9844 are unique to
the strain W3(cl) sequence. The difference at nt 4599 is unique to
the newly derivedW3 sequence and is also represented as an SNP,
with the minor variant being identical to the W3(cl) sequence.
From this point in the study, we used only the new consensus
sequence for strain W3. The length of the alignment of the 16
genome sequences was 15,252 nt, of which 1,192 positions
(7.82%, including a 6-nt insertion in some strains) were variable.
Among the variable positions, 842 positions represent differences
in1 sequence and are phylogenetically informative. Consistent
with the level of positional variability over the entire alignment,
the average pairwise difference is 2.1%, and no two sequences are
5% divergent (Table 2). The most divergent pair are the human
strain LNand the canine strainD277 (Table 2 [taking into account
additional decimal places not shown]).
A phylogenetic tree based on an alignment of the 16 genome
sequences is shown in Fig. 1. The primate strains cluster together
with 100% confidence, with the human cryptovirus sequence be-
ing the outlier in this group. The two porcine strains SER and
KNU-11, which were isolated in Germany and South Korea, re-
spectively (Table 1), are closely related to each other, with 100%
confidence, and cluster with 98% confidence with the canine vi-
ruses CPI and CPI, which were isolated in Germany (Table 1).
Strain CPI is formally a variant of strain CPI, which was iso-
lated from the brain of a dog with temporary posterior paralysis
and caused acute encephalitis when injected intracranially into
gnotobiotic dogs (16). The variant was isolated by those authors
from one such experimentally infected dog at 12 days postinfec-
TABLE 2 Data from pairwise comparisons of complete PIV5 genome sequencesa
Strain
No. of substitutions/nt site or 	 value
MEL MIL DEN LN RQ W3 Crypto SER KNU-11 CPI CPI 1168-1 78524 H221 08-1990 D277
MEL 1.25 2.40 0.99 1.73 0.13 0.13 0.20 0.22 0.13 0.14 0.12 0.10 0.11 0.13 0.13
MIL 0.001 1.13 0.80 1.25 0.13 0.13 0.19 0.22 0.13 0.14 0.12 0.09 0.10 0.13 0.13
DEN 0.001 0.001 0.64 1.40 0.12 0.12 0.18 0.21 0.13 0.13 0.11 0.09 0.10 0.12 0.12
LN 0.002 0.001 0.001 0.00 0.13 0.13 0.20 0.23 0.14 0.14 0.12 0.09 0.10 0.13 0.13
RQ 0.001 0.001 0.001 0.000 0.13 0.13 0.20 0.23 0.14 0.14 0.12 0.09 0.10 0.13 0.13
W3 0.015 0.015 0.014 0.015 0.015 0.21 0.44 0.43 0.21 0.23 0.22 0.13 0.15 0.15 0.15
Crypto 0.026 0.025 0.025 0.025 0.025 0.017 0.27 0.31 0.16 0.17 0.16 0.12 0.13 0.14 0.14
SER 0.020 0.020 0.019 0.020 0.020 0.011 0.018 0.89 0.25 0.28 0.35 0.17 0.19 0.17 0.16
KNU-11 0.022 0.022 0.022 0.023 0.022 0.014 0.020 0.005 0.28 0.29 0.39 0.20 0.22 0.18 0.18
CPI 0.029 0.029 0.029 0.029 0.029 0.021 0.026 0.017 0.019 1.62 0.18 0.12 0.14 0.14 0.14
CPI 0.030 0.030 0.029 0.030 0.030 0.022 0.027 0.017 0.020 0.001 0.19 0.13 0.14 0.14 0.14
1168-1 0.020 0.020 0.019 0.020 0.020 0.011 0.018 0.009 0.012 0.018 0.019 0.11 0.13 0.16 0.15
78524 0.027 0.027 0.026 0.027 0.027 0.020 0.025 0.017 0.020 0.026 0.027 0.013 0.28 0.14 0.13
H221 0.027 0.027 0.026 0.027 0.026 0.019 0.025 0.017 0.020 0.026 0.027 0.013 0.001 0.14 0.14
08-1990 0.044 0.044 0.043 0.044 0.044 0.036 0.043 0.032 0.036 0.041 0.042 0.030 0.028 0.027 0.11
D277 0.045 0.044 0.044 0.045 0.045 0.037 0.043 0.033 0.036 0.042 0.042 0.030 0.028 0.028 0.003
a The bottom left half shows the number of substitutions per nucleotide site. The top right half shows 	 values, with high values in boldface type. Crypto, cryptovirus.
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tion. Unlike strain CPI, variant strain CPI fails to block inter-
feron (IFN) signaling because of 3 amino acid substitutions in V,
leading to a loss of the ability to target STAT1 for proteasome-
mediated degradation (28). The greatest genetic diversity is appar-
ent among the canine strains, which were isolated in Germany,
South Korea, and the United Kingdom (Fig. 1 and Table 1). How-
ever, these strains cluster separately from the primate strains. Reg-
istering the caveat that confidence is
70% at the deepest nodes,
the longest path is between the cluster of human strains and two of
the SouthKorean canine strains (08-1990 andD277). In interpret-
ing the data on sequence relationships, we cannot rule out the
possibility that a degree of convergencemay have occurred during
propagation of the strains in Vero cells, which are unable to pro-
duce IFN. However, even if this were the case, it seems unlikely
that it was significant, as host-dependent phylogenetic clustering
of isolates was observed.
Sequence diversity amongPIV5 strains. In addition to illumi-
nating the relationships among PIV5 strains, the sequences also
provide information on the extent of variation along the genome,
thus potentially yielding insights into regions in which this factor
may relate to function. Diversity was analyzed in terms of nucle-
otide substitutions per site, expressed as (29), and was generally
highest at gene junctions. In particular, three regions of relatively
high variationwere identified as peaks (Fig. 2). The first centers on
nt 1700 and represents the C-terminal region ofN (approximately
residues 416 to 509), the 3= untranslated region (UTR) of the N
mRNA, the 5= UTR of the V/P mRNA, and the N-terminal region
of V and P (residues 1 to 76). The second centers on nt 4400 and
represents the C terminus of M (residues 366 to 377), the 3= UTR
of the MmRNA, the 5= UTR of the F mRNA, and the N terminus
of F (residues 1 to 24). The third centers on nt 6300 and represents
the 3=UTR of the FmRNA, the SH gene (examined inmore detail
below), and the 5= UTR of the HN mRNA.
A region of relatively moderate variation centers on nt 8300
and maps to the C-terminal region of HN (residues 524 to 565)
and the 3= UTR of the HN mRNA (Fig. 2). Since, owing to im-
mune selection, variationmight be expected in the viral glycopro-
teins, the amino acid substitutions in HN were scrutinized.
Unique residues are apparent in certain groups of strains, such as
most or all of the primate strains (L22, S49, G57, A254, S318,
T460, and T536), the primate and porcine strains (D447), and the
porcine strains (N120, T288, and S524). However, the level of
variation observed overall is modest and not notably greater than
that in other PIV5 proteins. Thus, although the substitutions ob-
served might reflect a degree of selection for antibody-mediated
evasion, the evidence is not compelling. A similar conclusion was
drawn previously for F (7), and our more extensive analysis did
not reveal any additional insights, with the exception that the
E132K change, whichwas observed previously only in nonprimate
strains, is not present in canine strain 1168-1. Also, strain W3 has
seven substitutions absent from HN in other strains (A10, S114,
M148, F209, G312, R368, and T491), which may be the result of
extensive laboratory adaptation or indicative of a simian origin. A
second simian isolate is required to distinguish between these two
possibilities.
Three areas of relatively low variation are also evident (Fig. 2).
The first centers on nt 2600 and corresponds to the C-terminal
regions of P and V (residues 165 to 351 and 165 to 222, respec-
tively). This part of the genome contains the overlapping protein-
coding regions of the V/P gene and the part of the P gene encoding
residues that interact with L (30). In the part of the genome that
encodes L, two regions are particularly well conserved. These re-
gions encompass approximately nt 10000 to 11200, which encode
the region (amino acid residues 716 to 931) responsible for RNA-
dependent RNA polymerase activity (31), and nt 12800 to 13500
(residues 1463 to 1696), which are of undetermined function.
All of the variation among PIV5 strains occurs as substitutions,
except for a 6-nt insertion in the region between the SH- and
HN-coding regions in strains LN and RQ, which are closely re-
lated to each other (Fig. 1 and Table 2). In most strains, the SH
transcriptional termination site is located after nt 6502 to 6515,
which (in the antigenome or mRNA sense) has the sequence 5=-U
UUUAAAGAAAAAA-3=, followed by an intergenic U residue.
Strains LN and RQ have an extended poly(A) site in this region
(5=-UUUUAAAGAAAAAGAAAAAA-3= [the insertion is under-
lined]). The functional significance of this additional sequence is
not known. However, the size of the insertion ensures that the
strain LN and RQ genomes, like those of the other strains, adhere
to the rule of six, whereby the genome sizes of certain paramyxo-
viruses occur in multiples of 6 nt (32).
FIG 1 Maximum likelihood phylogenetic tree derived from an alignment of
16 complete PIV5 genome sequences, rooted at the midpoint. Bootstrap con-
fidence values of70% (from 100 tests) are indicated. The scale indicates the
number of substitutions per site.
FIG 2 Nucleotide substitutions per site () measured in a 500-nt sliding
window along an alignment of 16 complete PIV5 genome sequences. Values
are plotted to correspond to the center of the window. The arrangement of
ORFs is indicated.
Stability of the Parainﬂuenza Virus 5 Genome
April 2014 Volume 88 Number 7 jvi.asm.org 3829
 o
n
 April 22, 2014 by G
lasgow University Library
http://jvi.asm.org/
D
ow
nloaded from
 
In order to analyze themode of PIV5 evolution, pairwise com-
parisons of the ratio of nonsynonymous to synonymous nucleo-
tide substitutions (	) were made (Table 2). A 	 value of 0 indi-
cates that nonsynonymous substitutions have been completely
suppressed, a 	 value of 1 indicates that neutral accumulation of
substitutions has occurred, and 	 values of1 indicate that pos-
itive selection may have taken place. Except in a few instances in
which sequences are very closely related and 	 values are statisti-
cally unsound as a result (data in boldface type in Table 2), 	
values for PIV5 strains isolated from various hosts are well below
1 (averaging 0.19), indicating that moderate to strong constraint
has been the prevailing selective mode. Values of 	 for individual
ORFs (Table 3) range from indicating strong selective constraint
in L to indicating near neutrality in SH. An analysis of positive
selection of specific amino acid residues revealed none at a signif-
icance level of a P value of 
0.01, and three candidate residues
(residues 447 in HN, 60 in M, and 31 in SH) were detected at a
lower significance level (P
 0.05). However, we consider that the
evidence for positive selection of specific PIV5 proteins, or resi-
dues therein, is not compelling.
The ratio of nucleotide transitions to transversions () for in-
dividual ORFs is shown in Table 3. The  value for the combined
protein-coding sequences is 8.17, which is somewhat higher than
that found thus far for other viruses in the subfamily Paramyxo-
virinae, such as measles virus, for which the  value is 5.1 (33, 34).
This overall value may have been enhanced by the high value for
SH, for which special considerations may apply (as discussed be-
low). The significance of the variation in  for the other genes is
not known.
As well as providing a view of diversity among the consensus
PIV5 sequences, the sequence data also yielded information on
variationwithin each of the 11 newly sequenced strains, detectable
as SNPs, whichwere recordedwhen theminor variant was present
in 2% of the sequence population (Table 4). The total number
was 111, and the number in each genome ranged from 0 in strain
MEL to 19 in strain DEN. With the exception of one SNP, it was
possible to infer from the genome sequence alignment which of
the two variant nucleotides at each SNPmost likely corresponds to
the original and which corresponds to the mutation. Most minor
variants (93/110; 85%) were inferred as representing mutations,
and the proportions of instances in which this is not the case
varied from genome to genome (e.g., they were more common in
strain MIL than in strain DEN). Among the SNPs located in the
ORFs, most (73/103; 71%) are nonsynonymous, perhaps indicat-
ing that the cognate variants may have been selected to detectable
levels because they conferred a growth advantage. Only a single
instance of an SNP shared among strains was discovered (nt 10755
in strains DEN and H221). It is notable that many of the SNPs in
strain MIL map in the region at nt 1326 to 1950, which corre-
sponds to the first peak of variation among strains (Fig. 2). There
appear to be an underrepresentation of SNPs in the M ORF (ob-
served/expected  0.38; P  0.05) and an overrepresentation in
the HN ORF (observed/expected  1.62; P  0.02). The other
ORFs and the nontranslated regions are represented as expected
from a random distribution of SNPs.
Functional analysis of the PIV5 SH gene.As described above,
one of the regions of relatively high variationmaps to the SH gene
(Fig. 2). This is due largely to a high level of U-to-C substitutions
in the genomes of most nonprimate strains relative to those of
primate strains (Fig. 3a). In this region, the primate strainsmay be
placed into three groups, since the human strains MEL, MIL,
DEN, LN, and RQ are identical. The nonprimate strains fall into
six groups, since the porcine strains SER and KNU-11 are identi-
cal, as are the canine strain CPI and its variant CPI and the
canine strains 78524 and H221. The canine strains 08-1990 and
D277 differ at a single nucleotide. Relative to strain MEL/MIL/
DEN/LN/RQ, various numbers of the 60 U residues in this region
are replaced by C residues in the other strains, as follows: 1 inW3,
3 in cryptovirus, 23 in SER/KNU-11, 20 in CPI/CPI, 2 in
1168-1, 3 in 8524/H221, and 21 in 08-1990/D277.
One of the U-to-C transitions in strains CPI/CPI and SER/
KNU-11 is located in the SH AUG initiation codon, resulting in
ACG. Moreover, the UAA termination codon is also mutated,
appearing as CAG in strain CPI/CPI and as CAA in strain SER/
KNU-11. The hypothesis that SH is not expressed by these strains,
as was adduced in relation to strain KNU-11 (22), was tested by
immunoblotting of lysates of Vero cells infected with strain W3,
strain CPI, variant strain CPI, or strain SER using a polyclonal
peptide antiserum raised against the N-terminal 16 residues of
strain W3 SH. The sequence of this region is well conserved
among strains (Fig. 3a), with the peptides in strains SER and
CPI/CPI differing from those in strainW3 by 0 and 1 residues,
respectively (not including the first residue). The results indicate
that strain W3 expressed SH, whereas strain CPI, variant strain
CPI, and strain SER did not express an SH-related protein of a
similar size (Fig. 3b) or larger (data not shown).
Sequence diversity of PIV5 passaged in cell culture.Todeter-
mine whether the relative stability of the PIV5 genome observed
among strains is also a feature of the virus passaged in vitro, the
strainW3 genome was examined during sequential passaging at a
high MOI in Vero cells. We generated this passage series previ-
ously, in order to analyze the production of PIV5 DI genomes
(mostly of the trailer copyback variety), which are powerful in-
ducers of the interferon response (17). Sequence data were ob-
tained for the input virus (W3vM0; the same data were used to
obtain the new sequence of strainW3) (Table 1) and passages 8 to
12 in the series (W3vM8 to W3vM12). The major DI genome in
W3vM12 accounted for 94% of all trailer copyback genomes (the
major variety of DI genome) and was identified previously as re-
sulting from the joining of nt 15062 (on the 5=-to-3= strand) to nt
14496 (on the 3=-to-5= strand) (17). The proportion of non-DI
genomes in the population was estimated by aligning the reads
separately to the nondefective and defective regions of the genome
and deriving average read coverage values. This analysis indicated
that W3vM8 to W3vM12 consisted of approximately 89, 86, 89,
94, and 98% DI genomes, respectively. For this exercise, W3vM0
was assumed essentially to lack DI genomes, and indeed, no reads
TABLE 3 Values of 	 and  in 16 PIV5 genomes for individual ORFs
ORF Size (nt) 	 
NP 1,530 0.13 11.99
V 669 0.32 11.90
P 1,179 0.38 9.67
M 1,134 0.15 6.64
F 1,590 0.29 7.68
SH 135 0.87 21.31
HN 1,698 0.24 5.71
L 6,768 0.11 7.26
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TABLE 4 SNPs in the PIV5 genome sequences determined in this study
Straina
Position
(nt)b
Major
variantc
Minor
variantc
Minor variant
frequency (%)
ORF(s) or
region
affected
Coding
difference(s)d
MIL 71 a G 8 N 5= UTR None
1462 c U 30 N None
1493 c U 31 N H448Y
1511 U c 17 N Y454H
1601 c U 26 N None
1645 U c 26 N None
1715 U c 13 V/P 5= UTR None
1746 U c 12 V/P 5= UTR None
1764 U c 12 V/P 5= UTR None
5544 C a 6 F Q339K
6884 u C 33 HN F101L
6885e U c 10 HN F101P
11799 A g 5 L K1129R
13697 u C 10 L Y1762H
DEN 1471 A g 6 N None
1561 U c 2 N None
1650 U c 43 N L500P
1737 U c 8 N 3= UTR None
3620 A g 42 M I160M
4218 A c 3 M N360H
5840 A g 42 F None
7216 A g 8 HN None
7698 C u 45 HN T372I
9662 G u 24 L V417L
10755 C u 14 L T781I
10837 A g 8 L None
12406 A g 18 L None
12463 A c 6 L None
12491 U c 3 L F1360L
13810 A g 33 L None
14421 C u 25 L A2003V
14723 A g 38 L R2104G
14982 U c 8 L L2190S
LN 5259 A g 5 F I244V
6938 u C 42 HN None
14975 U c 2 L None
RQ 14291 A g 8 L T1958A
14965 U c 5 L None
W3 25 u C 47 Leader None
4599 a G 25 F T24A
5807 C u 5 F None
5879 C u 15 F None
7702 U g 29 HN N373K
14927 A g 20 L N2172D
PIV5VCp6f 25 u C 44 Leader None
9356 C u 34 L H315Y
11870 c U 48 L None
SER 570 C u 10 N T140I
1227 g A 48 N R359K
4709 G c 12 F None
8201 A c 19 HN I540L
9191 U c 39 L Y260H
9658 U a 9 L H415Q
9995 G u 9 L V528L
10356 A g 3 L D648G
11598 U c 5 L I1062T
14156 C U 11 L R1915C
CPI 1520 G a 6 N E457K
1891 U c 5 V, P None
1925 U c 6 V, P Y26H
1998 U c 6 V, P L50P
2395 U c 14 V, P None, M183T
TABLE 4 (Continued)
Straina
Position
(nt)b
Major
variantc
Minor
variantc
Minor variant
frequency (%)
ORF(s) or
region
affected
Coding
difference(s)d
2618 A g 4 P I257M
5364 A g 15 F T279A
6708 A g 5 HN Q42R
6878 A g 14 HN K99E
7224 A g 12 HN K214R
8142 A g 8 HN E520G
9105 C u 16 L T231I
9184 U c 11 L None
10135 U g 16 L None
12492 U c 16 L F1360S
12529 A c 8 L None
13390 C u 11 L None
14775 a G 15 L D2121G
CPI 1435 U c 4 N None
6889 A c 11 HN Q102H
7128 U a 6 HN L182Q
7803 A c 26 HN N407T
8141 G a 6 HN E520K
10513 A u 22 L None
11896 A g 5 L None
13318 U a 11 L None
15221 u G 46 Trailer None
78524 3382 G a 4 M R81K
5620 G a 9 F S364N
5862 G a 10 F D445N
7145 C u 43 HN H188Y
7146 A g 24 HN H188R
7679 C u 11 HN P366S
10765 A g 9 L None
13712 A g 7 L N1767D
13731 C u 15 L T1773I
14159 G a 8 L A1916T
14189 C u 2 L P1926S
14313 U g 10 L F1967C
14355 C a 6 L A1981D
14360 C u 14 L H1983Y
14503 C a 4 L H2030Q
14506 A u 14 L L2031F
14532 C u 4 L A2040V
14993 U g 3 L Y2194D
H221 2319 c U 4 V, P S157F
2765 a U 5 P K306N
4295 C a 5 M 3= UTR None
7023 A c 4 HN N147T
7058 a G 4 HN K159E
9712 A g 13 L None
10755 C u 3 L T781I
12400 A g 3 L None
13032 C a 13 L P1540Q
13703 U g 5 L F1764V
13874 u C 4 L None
14349 a G 46 L D1979G
a No SNPs were detected in strain MEL.
b In the genome sequence of the relevant strain.
c The original nucleotide inferred from the alignment of PIV5 genome sequences is
shown in uppercase type, and the mutant nucleotide is shown in lowercase type. In the
single instance where an inference could not be made (nt 14156 in strain SER), both
nucleotides are shown in uppercase type.
d The amino acid residue in the major population is shown to the left of the position in
the relevant protein, and that in the minor population is shown to the right. Note that
the original nucleotide may correspond to the major or minor population (see above).
e The minor variant at nt 6885 is linked to that at nt 6884.
f The four clustered SNPs associated with pseudoreversion in the V ORF are not listed
and are instead described in the text.
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representing the novel junction in the major DI genome were
detected.
A total of 11 SNPs reached an abundance of5% in at least one
of the passagesmonitored (Table 5). Replacement of theU residue
at nt 14 by Cwas linked to replacement of the C residue at nt 25 by
U. These SNPs are located in the promoter at the 3= end of the
genome, and strikingly, the emerging variants dominated the viral
population in W3vM12. Some of the other SNPs present in
W3vM0 increased in abundance (at nt 2482, 10442, 11967, and
13261), and some decreased (at nt 4599, 5807, 5879, 7702, and
14927; the last was present in themajor DI genome, and it was not
possible to ascertain whether it was also present in the non-DI
genome population). These results show that, even over 12 pas-
sages in vitro and under conditions where nondefective genomes
were subjected to competition from an overwhelming proportion
of DI genomes, the nondefective sequences exhibited little diver-
sity.
In a further investigation of the stability of PIV5 in cell culture,
we utilized PIV5VC,which is amutant derived from amolecular
clone of strain W3. In this mutant, two translational termination
codons have been introduced into the V ORF via substitutions of
3 nt that do not affect the amino acid sequence of P but result in
expression of a truncated version of V lacking the C-terminal re-
gion (27) (Fig. 4a and b). Passaging of this virus in various cell
lines, including Vero, has been shown to result in rapid mutation
to a derivative that expresses full-length V, via substitutions in
both of the introduced termination codons (27). To monitor this
process of pseudoreversion in greater detail, the virus was pas-
saged 6 times inVero cells to generate a stock named PIV5VCp6.
Seven SNPs were detected in PIV5VCp6. Three were located
outside the V ORF (Table 4), and four were located in the V ORF
(nt 2357, 2362, 2363, and 2372). The latter SNPs were U-to-C
substitutions (sub1, sub2, sub3, and sub4) and are listed in Fig. 4c.
Two (sub1 and sub3) are the same as those reported previously
(27). The original sequence plus all arrangements of the four sub-
stitutions may result, in principle, in 16 different sequence con-
FIG 3 Effects of variation in the PIV5 SH gene on expression of SH. (a) Alignment of genome sequences (in the antigenome or mRNA sense) in the region at nt
6264 to 6473. The line divides primate strains (top) from nonprimate strains (bottom). U-to-C transitions, other transitions, and transversions are shaded black,
light gray, and dark gray, respectively, generally for nonprimate strains in relation to primate strains. The amino acid sequence of strainW3SH is also shown,with
the peptide against which the SH antibody was used in panel b shaded light gray. (b) Immunoblot of mock-infected cells (M) and cells infected with PIV5 strains
W3, CPI, CPI, and SER, probed with antibodies against PIV5 SH, PIV5 P, and cellular actin.
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stellations. However, only five (PIV5VC, sub13, sub134, sub123,
and sub1234) were detected in 0.2% of PIV5VCp6 genomes,
together summing to 99.58% (Fig. 4d to h). The two changes
(sub1 and sub3) in the termination codons resulted in full-length
V containing an amino acid substitution (F170Q), and a third
change (sub4) added a second amino acid substitution in V
(Y175H), to generate the major variant (sub134) (Fig. 4f). In ad-
dition, a substitution in P was detected at lower levels (sub2, as
represented in sub123 and sub1234) (Fig. 4g and h). This experi-
ment again demonstrated the relative stability of the PIV5 genome
during passage at a highMOI and also showed that adaptation can
nonetheless occur rapidly when a selection pressure is exerted.
The two substitutions (sub2 and sub4) not associated with pseu-
doreversion of the termination codons were not detected in a pre-
vious experiment (27), and in our experiment, it is possible that
they were not selected in their own right but were subsidiary to
sub1 and sub3.
DISCUSSION
We generated 11 genome sequences for 10 PIV5 strains and a
variant of one of these strains (Table 1). The incorporation of
published genome sequences for other strains facilitated the phy-
logenetic analysis of a total of 15 strains and the variant. In the tree
(Fig. 1), the primate strains cluster together, as do the porcine
strains, but there is much greater diversity among the canine
strains. Nonetheless, there is remarkable sequence conservation
overall, even though the strains originated from a variety of hosts
andwere isolated from awide geographical area during a period of
several decades (Tables 2 to 4). Surprisingly, the level of variation
in HN and F, which are targets for antibody-mediated virus neu-
tralization, was not significantly greater than that observed in
most other viral proteins. Amino acid residues 342, 437, and 457
in HN have been linked to promoting resistance to neutralizing
antibodies (35). However, with the exception of a Q342K substi-
tution in two of the South Korean canine isolates, variation in
these, or intervening, residues was not observed. Overall, these
results suggest that antibody-mediated selection has not played a
major role in the evolution of the PIV5 strains analyzed, perhaps
because the virus is not particularly immunogenic or because cell-
mediated immunity is more important in controlling PIV5 infec-
tions.
The RNA polymerases of paramyxoviruses, like those of most
other RNA viruses, lack proofreading mechanisms and therefore
have high error rates, resulting in the continual production of
TABLE 5 SNPs during passage of PIV5 strain W3
Position
(nt)
Major
varianta
Minor
varianta
ORF(s) or
region affected
Coding
difference(s)b Kineticsc
Minor variant frequency (%)d
W3vM0 W3vM8 W3vM9 W3vM10 W3vM11 W3vM12
14 U c Leader None I 0.00 93.88 97.43 97.67 99.51 98.28
25 u C Leader None D 47.03 0.00 0.44 0.33 0.21 0.43
2482 U c V, P None, V212A I 0.11 4.45 7.89 13.45 16.37 19.35
4599 a G F T24A D 24.77 0.18 0.44 0.15 0.31 0.29
5807 C u F None D 5.28 0.03 0.00 0.00 0.04 0.00
5879 C u F None D 14.91 0.03 0.00 0.07 0.04 0.09
7702 U g HN N373K D 29.35 2.78 2.21 1.50 1.09 0.74
10442 A c L I677L I 0.03 4.91 5.85 7.76 8.75 9.84
11967 C a L A1185D I 0.03 4.64 6.83 7.99 9.36 8.51
13261 A c L L1616F I 0.02 3.67 7.41 12.28 13.91 13.46
14927 A g L N2172D D 19.64 12.87 10.53 12.46 7.96 5.31
a The original nucleotide inferred from the PIV5 genome alignment is shown in uppercase type, and the mutant nucleotide is shown in lowercase type.
b The amino acid residue in the major population is shown to the left of the position in the relevant protein, and that in the minor population is shown to the right. Note that the
original nucleotide may correspond to the major or minor population.
c I, increasing in proportion during passage; D, decreasing in proportion during passage.
d The numbers of reads obtained (with the proportions that aligned to the strain W3 genome sequence in parentheses) were as follows: W3vM0, 21,156,178 (78%); W3vM8,
3,233,587 (59%); W3vM9, 3,210,385 (30%); W3vM10, 3,473,827 (42%); W3vM11, 3,636,000 (51%); W3vM12, 3,789,267 (37%).
FIG 4 Variation in a region of the PIV5 V/P gene after passaging of PIV5VC
6 times in Vero cells to generate PIV5VCp6. The number of reads that
aligned to the complete PIV5VC genome sequence was 22,456,971 (71% of
the total). (a) The RNA sequence in W3 and its translation as part of P and V,
with coordinates in the genome or amino acid sequences on the right. (b) The
RNA sequence in PIV5VC and its translation, with substitutions shaded gray
and introduced termination codons in theV gene heavily underlined. The light
underlining indicates the flanking sequences that were utilized to isolate reads
for analysis of SNPs. (c) The four substitutions (sub1 to sub4) detected in this
region of PIV5VCp6. (d to h) The fivemajor sequence constellations of sub1
to sub4 (parental PIV5VC, sub13, sub134, sub123, and sub1234), with per-
centages of reads on the right. Nucleotide and amino acid substitutions, in
comparison with PIV5VC, are shaded gray.
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large numbers ofmutants during replication.Consequently, when
a selection pressure is sufficiently strong, for example, in the case
of PIV5VC, which lacks a functional V ORF, mutations are gen-
erated with facility. In this context, it is striking that the PIV5
genome, as represented by the range of strains studied, exhibits so
little diversity. Indeed, even the level of synonymous mutations
among strains is impressively low and similar to what has been
reported for another rubulavirus, mumps virus (36, 37), and a
morbillivirus, measles virus (38). The low level of variation in
PIV5 is also similar to that observed in humanPIV3 isolates.How-
ever, the level of variation observed between human and bovine
PIV3 isolates is about six times greater than that observed between
PIV5 strains isolated from different species.
The reasons for the low levels of diversity in paramyxoviruses
are not understood. Constraints potentially operate at several lev-
els, affecting recognition by innate immune responses or the level
and rate of protein translation, including biases against specific
dinucleotides (39), biases in codon usage (recently shown to be
important inHIV-1 replication) (40), and codon pair context (41,
42). Codon usage appears to be able to exert an unexpectedly large
effect on translational efficiency in somemicrobial organisms (43)
and also appears to be virus specific, rather than host specific, in
the subfamily Paramyxovirinae (B. K. Rima, unpublished data).
Since paramyxovirus genomes are always encapsidated, secondary
structures in the genomes or antigenomes are unlikely to provide
a significant constraint on synonymous mutations. However,
mRNA secondary structure can influence the rate of protein trans-
lation and thus affect indirectly the proper folding of nascent pro-
teins (44). Finally, it must be registered that any RNA virus enters
the RNAworld of the host cell and thus must avoid the formation
of double-stranded RNA (dsRNA) structures with complemen-
tary cellular RNAs, including microRNAs (miRNAs).
The rule of six (32) appears to be an important factor in the
fitness of members of the subfamily Paramyxovirinae. Its rele-
vance is demonstrated in our data by strains RQ and LN, which
have an insertion of 6 nt at the 3= end of the SH gene. Since the SH
gene of PIV5 is dispensable for growth in cell culture (21), the
effect of this insertion cannot be evaluated easily. Toleration of a
certain level of diversity at the 3= end of rubulavirus mRNAs may
be seen in a variation in the mumps virus F gene, which led to the
insertion of oligo(G) tracts immediately prior to the poly(A) tail
without affecting viral growth in vivo (37).
The rule of six has been interpreted as indicating that all nucle-
otides in a genome must be attached to N molecules in groups of
six (32). This, in turn, has established the concept of “phase,” that
is, the position of a nucleotide within a specific group of six. The
phases (phases 1 to 6) of the 5= nucleotides of each of the mRNAs
in all the PIV5 genomes show strong overall conservation, similar
to other paramyxoviruses (45). If phase is an important feature of
rubulaviruses, it might operate as a constraint on the occurrence
of synonymous mutations. However, most of the variation in
PIV5 strains is clustered in three regions between (i) the ORFs of
the N and V/P proteins, (ii) the M and F ORFs, and (iii) the F and
HN ORFs, including the entire SH gene (Fig. 2). The implication
that constraint has operated primarily on protein-coding se-
quences is consistent with the observation that following the loss
of protein function, many synonymous and (potentially) nonsyn-
onymous mutations have accumulated, as observed for the SH
gene in strains CPI/CPI and SER.
Analysis of variation in the PIV5 SH gene indicated a prepon-
derance of U-to-C substitutions in many of the nonprimate
strains. As a mechanism, this suggests biased hypermutation due
to an adenosine deaminase, RNA-specific 1 (ADAR1)-like activity
that deaminatesA residues in dsRNA to I residues, which then pair
preferentially with C residues in subsequent rounds of replication
(46). At some point, mutations in strains CPI/CPI and SER/
KNU-11 have led to a change in the AUG initiation codon for SH
to ACG (Fig. 3). Although ACG can act as an initiation codon in
certain circumstances, for example, in expression of the Y proteins
in Sendai virus (47), in PIV5 strains CPI/CPI and SER, this
change, perhaps in combination with others, has led to a lack of
expression of SH. The function of SH is unclear, but recent studies
have reported that it inhibits tumor necrosis factor alpha (TNF-
)-induced apoptosis (48–50). In certain cell types, such as bovine
kidney (MDBK) cells, PIV5 causes little cytopathic effect, but
when MDBK cells were infected with recombinant PIV5 lacking
the SHgene, an increased cytopathic effect was observed (48).Our
results indicate that the SH gene was lost some time ago, as strains
CPI/CPI and SERwere isolated in the 1970s and 1990s, respec-
tively (Table 1), and this absence has been maintained in strain
KNU-11, which was isolated in 2011 (22). In regard to strain
CPI/CPI, it seems very likely, given the genetic stability of
PIV5, that the loss of the ability of variant strainCPI to block IFN
signaling was selected in vivo, possibly because IFN-sensitive vi-
rusesmay be better able to establish prolonged or persistent infec-
tions (28).
Our study also shows that PIV5 also exhibits little diversity
when passaged in cell culture. Thus, serial passaging of strain W3
at a high MOI, under conditions of competition with large pro-
portions of DI genomes, generated only a modest number of mu-
tations (Table 5). Although it would not be expected that compe-
tition with DIs would necessarily lead to the selection of
nonsynonymous mutations, it was striking that, despite the fact
that the PIV5 genome is not codon optimized, the only synony-
mousmutations selectedwere in the region of the leader promoter
and that no other synonymous mutations were coselected with
these promoter mutations. Similar observations were made for
the mutant lacking V function (PIV5VC), in which mutations
were confined largely to pseudoreversion events in the V ORF
(Fig. 4). As has been reported previously (27), it is clear that there
is strong selection to remove the termination codons and allow
expression of intact V, in which the C-terminal zinc fingermotif is
the most conserved element in members of the subfamily
Paramyxovirinae. Pseudoreversion occurred even though the vi-
rus was passaged in Vero cells, which are not able to induce IFN.
Thus, the pressure to regainV function cannot be related to block-
ing of the IFN response and is presumably due to a restoration of
some other important function of V, for example, in controlling
viral transcription or replication. A number of mutations could
potentially have arisen in PIV5VC that would have led to the loss
of the termination codons, but the only pseudorevertants detected
in our study and in a previously reported experiment (27) in-
volved replacement of U by C residues (sub1 and sub3). In our
experiment, two other U-to-C transitions also occurred closely
adjacent to the termination codons (sub2 and sub4). These find-
ings again suggest the operation of biased hypermutation, al-
though (as discussed above for SH) an intrinsic bias of the RNA
polymerase cannot be ruled out.
In conclusion, the sequences of PIV5 strains indicate that the
genome exhibits little diversity in vivo and in vitro. However, the
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identity of themain animal reservoir of PIV5 remains unclear. SH
appears to be dispensable for growth in dogs and pigs (although
further experimentation will be needed to the determine the con-
sequences, if any, of the loss of SH on PIV5 pathogenesis in dogs
and pigs), and the absence of SH from some strains isolated from
these animalsmay imply that they are not the natural hosts.More-
over, the fact that PIV5 is not known to cause detectable disease in
humans, whereas infections in dogsmay be severe, could be inter-
preted as indicating that humans are the reservoir host from
which PIV5 has transferred into dogs and pigs. If so, this might
explain why monkeys brought into captivity apparently become
infected by PIV5 through contact with humans. To resolve the
question of the origins of PIV5, many more strains from various
sources need to be analyzed, particularly from geographical loca-
tions where dogs are not immunized against PIV5.
Finally, the findings based on the sequence information pre-
sented here raise questions that will form the basis of a number of
future mechanistic studies, including (i) investigating the role of
ADARand themechanisms that underlie biased hypermutation in
viruseswith encapsidated genomes; (ii) determiningwhy there are
relatively few synonymous mutations in viruses isolated over de-
cades and from different species, given that the PIV5 genome is
not codon optimized; (iii) elucidatingwhat the selection pressures
are on PIV5VC to make it revert so quickly in the absence of a
host cell IFN response; and (iv) determining why antibody-medi-
ated immune selection appears not to be a major driving force in
PIV5 evolution.
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